The Detection of HER2 Gene Amplification in Breast Cancer by upQMPSF

The amplification of human epidermal growth factor receptor 2 (HER2) gene in breast cancer identifies patients eligible for Trastuzumab therapy. immunohistochemistry (IHC) and/or fluorescent in situ hybridization (FISH) are the only FDA approved techniques for evaluating HER2 status. However, Interobserver variability is still a dilemma
The Detection of HER2 Gene Amplification in Breast Cancer by upQMPSF QR

تاريخ النشر

22 - سبتمبر - 2017

أصناف البحث

  • علمية

المؤلفون

  • سامي أزرق
جامعة الأندلس الخاصة للعلوم الطبيّة